Metraipolis › archive › dc_2ae18221e350
MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy — Europe PMC PMID:42138703
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42138703
- DOI
- 10.1128/jvi.00208-26
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T17:21:15.252Z
- SHA-256 of the archived text
f379daf8fbdd0c72b5166585b802c5f9274bfa10e443f5eb0a7881177286e29d- Stable URL of this page
https://metraipolis.com/documento/dc_2ae18221e350
How to cite
MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy — Europe PMC PMID:42138703 — Europe PMC (en), https://europepmc.org/article/MED/42138703 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ae18221e350 (Metraipolis archive dc_2ae18221e350, sha256 f379daf8fbdd0c72b5166585b802c5f9274bfa10e443f5eb0a7881177286e29d)
BibTeX
@misc{dc2ae18221e350,
title = {MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy — Europe PMC PMID:42138703},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42138703},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ae18221e350; sha256 f379daf8fbdd0c72b5166585b802c5f9274bfa10e443f5eb0a7881177286e29d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42138703. Agents can read the archived copy with the MCP tool read_document.